207 related articles for article (PubMed ID: 16675486)
1. Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer.
Veronesi U; Mariani L; Decensi A; Formelli F; Camerini T; Miceli R; Di Mauro MG; Costa A; Marubini E; Sporn MB; De Palo G
Ann Oncol; 2006 Jul; 17(7):1065-71. PubMed ID: 16675486
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.
Veronesi U; De Palo G; Marubini E; Costa A; Formelli F; Mariani L; Decensi A; Camerini T; Del Turco MR; Di Mauro MG; Muraca MG; Del Vecchio M; Pinto C; D'Aiuto G; Boni C; Campa T; Magni A; Miceli R; Perloff M; Malone WF; Sporn MB
J Natl Cancer Inst; 1999 Nov; 91(21):1847-56. PubMed ID: 10547391
[TBL] [Abstract][Full Text] [Related]
3. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
Decensi A; Veronesi U; Miceli R; Johansson H; Mariani L; Camerini T; Di Mauro MG; Cavadini E; De Palo G; Costa A; Perloff M; Malone WF; Formelli F
Clin Cancer Res; 2003 Oct; 9(13):4722-9. PubMed ID: 14581342
[TBL] [Abstract][Full Text] [Related]
4. Fenretinide breast cancer prevention trial: drug and retinol plasma levels in relation to age and disease outcome.
Formelli F; Camerini T; Cavadini E; Appierto V; Villani MG; Costa A; De Palo G; Di Mauro MG; Veronesi U
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):34-41. PubMed ID: 12540501
[TBL] [Abstract][Full Text] [Related]
5. Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.
Decensi A; Robertson C; Guerrieri-Gonzaga A; Serrano D; Cazzaniga M; Mora S; Gulisano M; Johansson H; Galimberti V; Cassano E; Moroni SM; Formelli F; Lien EA; Pelosi G; Johnson KA; Bonanni B
J Clin Oncol; 2009 Aug; 27(23):3749-56. PubMed ID: 19597031
[TBL] [Abstract][Full Text] [Related]
6. Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.
Macis D; Gandini S; Guerrieri-Gonzaga A; Johansson H; Magni P; Ruscica M; Lazzeroni M; Serrano D; Cazzaniga M; Mora S; Feroce I; Pizzamiglio M; Sandri MT; Gulisano M; Bonanni B; Decensi A
J Clin Oncol; 2012 Jan; 30(2):151-7. PubMed ID: 22162577
[TBL] [Abstract][Full Text] [Related]
7. Safety of the synthetic retinoid fenretinide: long-term results from a controlled clinical trial for the prevention of contralateral breast cancer.
Camerini T; Mariani L; De Palo G; Marubini E; Di Mauro MG; Decensi A; Costa A; Veronesi U
J Clin Oncol; 2001 Mar; 19(6):1664-70. PubMed ID: 11250995
[TBL] [Abstract][Full Text] [Related]
8. Fenretinide in the prevention of breast cancer in premenopausal women: fluke or fact?
Pritchard KI
Ann Oncol; 2006 Jul; 17(7):1035-6. PubMed ID: 16766581
[No Abstract] [Full Text] [Related]
9. Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer.
Decensi A; Johansson H; Miceli R; Mariani L; Camerini T; Cavadini E; Di Mauro MG; Barreca A; Gonzaga AG; Diani S; Sandri MT; De Palo G; Formelli F
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1047-53. PubMed ID: 11588130
[TBL] [Abstract][Full Text] [Related]
10. Effect of fenretinide on ovarian carcinoma occurrence.
De Palo G; Mariani L; Camerini T; Marubini E; Formelli F; Pasini B; Decensi A; Veronesi U
Gynecol Oncol; 2002 Jul; 86(1):24-7. PubMed ID: 12079295
[TBL] [Abstract][Full Text] [Related]
11. Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.
Johansson H; Bonanni B; Gandini S; Guerrieri-Gonzaga A; Cazzaniga M; Serrano D; Macis D; Puccio A; Sandri MT; Gulisano M; Formelli F; Decensi A
Breast Cancer Res Treat; 2013 Dec; 142(3):569-78. PubMed ID: 24241787
[TBL] [Abstract][Full Text] [Related]
12. Synthetic retinoid fenretinide in breast cancer chemoprevention.
Bonanni B; Lazzeroni M; Veronesi U
Expert Rev Anticancer Ther; 2007 Apr; 7(4):423-32. PubMed ID: 17428163
[TBL] [Abstract][Full Text] [Related]
13. Re: Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.
Ménard S; Camerini T; Mariani L; Tomasic G; Pilotti S; Costa A; De Palo G; Veronesi U
J Natl Cancer Inst; 2001 Feb; 93(3):240-1. PubMed ID: 11158198
[No Abstract] [Full Text] [Related]
14. Fenretinide and cancer prevention.
Torrisi R; Decensi A
Curr Oncol Rep; 2000 May; 2(3):263-70. PubMed ID: 11122852
[TBL] [Abstract][Full Text] [Related]
15. The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients.
Torrisi R; Pensa F; Orengo MA; Catsafados E; Ponzani P; Boccardo F; Costa A; Decensi A
Cancer Res; 1993 Oct; 53(20):4769-71. PubMed ID: 8402658
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women.
Guerrieri-Gonzaga A; Robertson C; Bonanni B; Serrano D; Cazzaniga M; Mora S; Gulisano M; Johansson H; Formelli F; Intra M; Latronico A; Franchi D; Pelosi G; Johnson K; Decensi A
J Clin Oncol; 2006 Jan; 24(1):129-35. PubMed ID: 16382122
[TBL] [Abstract][Full Text] [Related]
17. Fenretinide and risk reduction of second breast cancer.
Decensi A; Zanardi S; Argusti A; Bonanni B; Costa A; Veronesi U
Nat Clin Pract Oncol; 2007 Feb; 4(2):64-5. PubMed ID: 17259924
[No Abstract] [Full Text] [Related]
18. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide.
Costa A; Formelli F; Chiesa F; Decensi A; De Palo G; Veronesi U
Cancer Res; 1994 Apr; 54(7 Suppl):2032s-2037s. PubMed ID: 8137334
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of breast cancer with fenretinide.
Torrisi R; Decensi A; Formelli F; Camerini T; De Palo G
Drugs; 2001; 61(7):909-18. PubMed ID: 11434448
[TBL] [Abstract][Full Text] [Related]
20. Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?
Cazzaniga M; Varricchio C; Montefrancesco C; Feroce I; Guerrieri-Gonzaga A
J Biomed Biotechnol; 2012; 2012():172897. PubMed ID: 22500077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]